Dynavax Technologies Corporation
N/A
USD
N/A
N/A
...
Chart
Financials
Description
DVAX Company Description
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
DVAX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view DVAX Smart Score
Score Breakdown
DVAX Company Description
Show More
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of DVAX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DVAX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on DVAX's company Twitter account
WallStreetBets
Number of mentions of DVAX in WallStreetBets Daily Discussion
DVAX News
Recent insights relating to DVAX
CNBC Recommendations
Recent picks made for DVAX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in DVAX
Corporate Flights
Flights by private jets registered to DVAX
Our Analysis